Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 219-283-9 | CAS number: 2402-79-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 29 May 1991 to 24 February 1992
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP study conducted in compliance with agreed protocols, with no or minor deviations from standard test guidelines.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 992
- Report date:
- 1992
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- Deviations:
- no
- GLP compliance:
- yes
- Type of assay:
- micronucleus assay
Test material
- Reference substance name:
- 2,3,5,6-tetrachloropyridine
- EC Number:
- 219-283-9
- EC Name:
- 2,3,5,6-tetrachloropyridine
- Cas Number:
- 2402-79-1
- Molecular formula:
- C5HCl4N
- IUPAC Name:
- 2,3,5,6-tetrachloropyridine
- Details on test material:
- Reference: AGR 0289294
Batch number: WP-900914-748
Purity = 98.6%
Constituent 1
Test animals
- Species:
- mouse
- Strain:
- CD-1
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- Male and female CD-1 (ICR) BR (abbreviated as CD-1) mice, approximately 8 weeks old, were used in the study. The mice were ordered from Charles River Laboratories, Inc., of Wilmington, MA. This strain of mouse was selected because of its (1) suitability for use in the micronucleus test, (2) general acceptance for short-term testing, and (3) availability of spontaneous micro¬nucleus rates. Upon arrival, the animals were examined by a veterinarian and found to be in good health. The mice were housed singly in suspended wire-bottom cages with computer generated, unique identification numbers. The mice were eartagged with identification numbers. Dustless, neomycin-impregnated cage boards were used to retard formation of unpleasant odors and to aid in the maintenance of a clean environment. Upon receipt, the mice were allowed to acclimatize for at least a week in a room designed to maintain adequate environ¬mental conditions with regard to temperature and humidity. The animals were maintained in the same environment during the remainder of the study. The mice were fed on Purina Certified Rodent Chow #5002 (Purina Mills, Inc., Richmond, IN). The chow is certified to contain no more than the specified maximum concentrations of heavy metals, organo¬phosphates, chlorinated hydrocarbons, PCB's, aflatoxins, and to have been manufactured in a plant where antibiotics and synthetic estrogens are prohibited. Municipal water was available to the animals at all times via pressure-activated water outlets. Records of periodic water analysis and feed certification are maintained at the laboratory.
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- Corn oil
- Details on exposure:
- All doses of the test material and positive control substance cyclophosphamide (CP) were administered by single oral gavage. In both the range-finding test and the micronucleus assay, the test material was administered in aliquots of 10 ml/kgBW. Negative control mice received 10 ml/kgBW of corn oil. CP was administered in aliquots of 10 ml/kgBW.
- Duration of treatment / exposure:
- All doses of the test material and CP were administered by single oral gavage. Groups of animals were sacrificed at three intervals, viz., 24, 48, and 72 hours after treatment. Positve control mice treated with CP were sacrificed after 24 hours.
- Frequency of treatment:
- All doses of the test material and CP were administered by single oral gavage.
- Post exposure period:
- Groups of animals were sacrificed at three intervals, viz., 24, 48, and 72 hours after treatment. Positve control mice treated with CP were sacrificed after 24 hours.
Doses / concentrationsopen allclose all
- Remarks:
- Doses / Concentrations:
22.5, 75.0, 225.0 mg/kg bw (males)
Basis:
actual ingested
oral gavage
- Remarks:
- Doses / Concentrations:
93.0, 310.0, 930.0 mg/kg bw (females)
Basis:
actual ingested
oral gavage
- No. of animals per sex per dose:
- 5
- Control animals:
- yes, concurrent vehicle
- Positive control(s):
- Cyclophosphamide (CP, CAS No. 50-18-0) purchased from Sigma, St. Louis, MO, was used as a positive control chemical at a dose level of 120 mg/kgBW. This dose level was based upon the experience of this laboratory (Gollapudi et al., 1985) and was selected to induce an unequivocal positive response.
Examinations
- Tissues and cell types examined:
- Bone marrow.
- Details of tissue and slide preparation:
- At the end of the specified intervals following dosing, the animals were sacrificed by cervical dislocation. Bone marrow samples were obtained from both femurs in the following way. After separating the bone from the adjoining muscles, the distal end of the femur was severed to expose the marrow cavity. A 25-gauge needle was used to aspirate the bone marrow into a 3 ml syringe containing approximately 0.5 ml of fetal bovine serum (GIBCO, Grand Island, New York). After aspiration, the contents of the syringe were transferred into a 1.5 ml centrifuge tube containing 0.5 ml of serum. The cells were resuspended in the serum by gentle aspiration using the syringe and needle. The tubes were centrifuged at about 1000 rpm for approximately 5 minutes in a table-top centrifuge. The supernatant was discarded leaving a small amount of serum covering the pellet. The cell pellet was resuspended using a disposable transfer pipet. Wedge smears were prepared on microscope slides using small portions of the cell suspension. The slides were allowed to air dry and stained with Wright-Giemsa using a Hematek automatic slide stainer.
The slides were coded and scored blindly by a single investigator. One thousand polychromatic erythrocytes were examined from each animal and the number of micronucleated polychromatic erythrocytes (MN-PCE) was recorded. Micronuclei were identified as darkly stained bodies with sharp contours and varying shapes such as round, almond, or ring (Schmid, 1976). The ratio of PCE-NCE in the bone marrow was determined by examining 1000 erythrocytes per animal. The ratio was expressed as PCEx100/PCE+NCE.
- Evaluation criteria:
- Statistically significant increase in the fequencies of micronuceated bone marrow polychromatic eryhtrocytes.
- Statistics:
- The raw data on the counts of MN-PCE for each animal was first transformed by adding 1 to each count and then taking the natural log of the adjusted number. The transformed MN-PCE data and the data on percent PCE were analyzed separately by a three-way analysis of variance (sex, dose, and time) assuming the three-way interaction to be zero. From these initial analyses, the two-way interactions were reviewed for significance. Depending on these reviews, the data were analyzed by either one-, two-, or three-way analysis of variance looking at main effects only. Pairwise com¬parisons of treated vs. control groups were done, if necessary, by Dunnett's t-tests, one-sided (upper) for MNPCE and two-sided for percent PCE. The alpha level at which all the tests were conducted was 0.01.
The final interpretation of biological significance of the responses was based on both statistical outcome and scientific judgment.
Results and discussion
Test results
- Sex:
- male/female
- Genotoxicity:
- negative
- Toxicity:
- yes
- Vehicle controls validity:
- valid
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- The dose levels for the micronucleus assay were based on the outcome of a range finding assay in which toxicity was observed.
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information): negative
Based upon the results, it was concluded that the test chemical did not induce a significant increase in the frequencies of micronucleated bone marrow polychromatic erythrocytes when given as a single oral dose to male and female CD-1 mice. Hence, under the experimental conditions used, the test chemical was judged negative in the mouse bone marrow micronucleus test. - Executive summary:
A GLP compliant study conducted according to OECD, EEC and US EPA guidelines was conducted in order to assess the mutagenic potential of the test substance. Based upon the results, it was concluded that the test chemical did not induce a significant increase in the frequencies of micronucleated bonemarrow polychromatic erythrocytes when given as a single oral dose to maleand female CD-1 mice. Hence, under the experimental conditions used, the test chemical was judged negative in the mouse bone marrow micronucleus test.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.